- Amjevita is a biosimilar copy of Abbvie’s best-selling arthritis drug Humira.
- Ahead 300 is a handheld medical device that helps clinicians diagnose a traumatic brain injury.
- Dublin-based Medtronic developed the MiniMed 670G, an artificial pancreas for patients with type 1 diabetes.
- Llaris, an anti-inflammatory drug developed by Basel, Switzerland-based Novartis, can now be used to treat three more rare auto-inflammatory diseases.
- New Brunswick, N.J.-based Johnson & Johnson’s anti-inflammatory drug Stelara can now be used to treat Crohn’s disease.
- The FreeStyle Libre Pro system is a continuous glucose monitoring system developed by Abbott Park, Ill.-based Abbott.
- Boston-based Vertex Pharmaceuticals’ cystic fibrosis drug Orkambi can now be used to treat children ages 6 to 11.
- The BD Vacutainer Barricor plasma blood collection tube separates plasma from whole blood samples.
More articles on supply chain:
Why EpiPens are so much cheaper in Europe
Uber to develop technology to connect truckers and carriers
Amgen, Arrowhead Pharma to collaborate on gene-silencing drugs
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
